The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 11, 2014

Filed:

Sep. 09, 2011
Applicants:

Ted M. Ross, Pittsburgh, PA (US);

Brendan M. Giles, Centennial, CO (US);

Inventors:

Ted M. Ross, Pittsburgh, PA (US);

Brendan M. Giles, Centennial, CO (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 14/11 (2006.01); A61K 39/145 (2006.01); C07K 14/005 (2006.01); C07K 14/08 (2006.01); C07K 14/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/11 (2013.01); C07K 2319/00 (2013.01); C12N 2760/16323 (2013.01); C12N 2760/16234 (2013.01); A61K 39/145 (2013.01); C12N 2760/16123 (2013.01); C12N 2760/16223 (2013.01); C12N 2760/16134 (2013.01); C12N 2760/16334 (2013.01); C12N 2760/16122 (2013.01); A61K 39/00 (2013.01); C07K 14/005 (2013.01); A61K 2039/5258 (2013.01);
Abstract

Described herein is the development of a computationally optimized influenza HA protein that elicits broadly reactive immune response to all H5N1 influenza virus isolates. The optimized HA protein was developed through a series of HA protein alignments, and subsequent generation of consensus sequences, for clade 2 H5N1 influenza virus isolates. The final consensus HA amino acid sequence was reverse translated and optimized for expression in mammalian cells. Influenza virus-like particles containing the optimized HA protein are an effective vaccine against H5N1 influenza virus infection in animals.


Find Patent Forward Citations

Loading…